The chemical evolution of oligonucleotide therapies of clinical utility
Crossref DOI link: https://doi.org/10.1038/nbt.3765
Published Online: 2017-02-27
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Khvorova, Anastasia
Watts, Jonathan K
Text and Data Mining valid from 2017-02-27
Article History
Received: 18 August 2016
Accepted: 12 December 2016
First Online: 27 February 2017
Competing interests
: A.K. owns stock in RXi Pharmaceuticals.